Coagulopathies in cyanotic cardiac patients: An analysis with three point - of - care testing devices (Thromboelastography, rotational thromboelastometry, and sonoclot analyzer)

Vandana Bhardwaj, Poonam Malhotra, Suruchi Hasija, Ujjwal Kumar Chowdury, Neha Pangasa, Vandana Bhardwaj, Poonam Malhotra, Suruchi Hasija, Ujjwal Kumar Chowdury, Neha Pangasa

Abstract

Introduction: In the last few years, viscoelastic point-of-care (POC) coagulation devices such as thromboelastography (TEG), rotational thromboelastometry (ROTEM), and Sonoclot (SON) analyzer have been increasingly used in major surgeries for timely assessment and management of coagulopathies. The aim of the present study was to evaluate coagulation profile of cyanotic cardiac patients with TEG, ROTEM, and SON analyzer. In addition, we assessed the correlation of standard laboratory coagulation tests and postoperative chest drain output (CDO) with the parameters of POC testing devices.

Materials and methods: Thirty-five patients of either gender, belonging to the American Society of Anesthesiologists Grade I-III, and undergoing elective cardiac surgery on cardiopulmonary bypass for cyanotic congenital heart disease were included in this study. To identify possible coagulation abnormalities, blood samples for TEG, ROTEM, SON, and standard laboratory coagulation were collected after induction of anesthesia. The correlations between variables were assessed using Pearson's correlation coefficient. P < 0.05 was considered statistically significant.

Results and discussion: EXTEM clot time (CT) and clot formation time (CFT) were prolonged in 87% and 45% patients whereas INTEM CT and CFT were prolonged in 36% and 73% patients, respectively. FIBTEM maximum clot firmness (MCF) was decreased in 30% patients. We observed significant correlation between fibrinogen concentration and ROTEM FIBTEM MCF (r = 0.94, P < 0.001). The SON platelet function (SON PF) showed good correlation with platelet count (r = 0.85, P < 0.001). We also found significant correlation between preoperative FIBTEM MCF and CDO in first 4 postoperative hours (r = 0.49, P = 0.004) and 24 postoperative hours (r = 0.52, P = 0.005). Receiver operating characteristic analysis demonstrated that SON PF and TEG maximum amplitude are highly predictive of thrombocytopenia below 100 × 109/L (area under the curve [AUC] - 0.97 and 0.92, respectively), while FIBTEM-MCF is highly predictive of hypofibrinogenemia (fibrinogen <150 mg/dL (AUC, 0.99).

Conclusion: Cyanotic cardiac patients have preoperative coagulation abnormalities in ROTEM, TEG, and SON parameters. ROTEM FIBTEM is highly predictive of hypofibrinogenemia while SON PF is highly predictive of thrombocytopenia. ROTEM FIBTEM can be studied as a marker of increased postoperative CDO.

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Correlation between fibrinogen concentration and point-of-care testing parameters. (a) Fibrinogen and thromboelastography alpha angle, (b) fibrinogen and thromboelastography maximum amplitude, (c) fibrinogen and rotational thromboelastometry FIBTEM maximum clot firmness. Note a strong correlation (c) between fibrinogen and FIBTEM maximum clot firmness (r = 0.94)
Figure 2
Figure 2
Correlation between platelet count, activated plasma thromboplastin time, and point-of-care parameters. (a) Platelet and Sonoclot platelet function, (b and c) platelet and rotational thromboelastometry FIBTEM maximum clot firmness (c) platelet and thromboelastography maximal amplitude
Figure 3
Figure 3
Receiver operating characteristic curves of Sonoclot platelet function, INTEM-maximum clot firmness, and thromboelastography-maximum amplitude for predicting thrombocytopenia (platelet count 9/L)
Figure 4
Figure 4
Receiver operating characteristic curves of FIBTEM-maximum clot firmness and thromboelastography-maximum amplitude for predicting hypofibrinogenemia (fibrinogen concentration

Figure 5

Correlation between rotational thromboelastometry FIBTEM…

Figure 5

Correlation between rotational thromboelastometry FIBTEM maximum clot firmness and chest drain output in…

Figure 5
Correlation between rotational thromboelastometry FIBTEM maximum clot firmness and chest drain output in first 4 postoperative hours (r = 0.49) (a) and 24 postoperative hours (r = 0.52) (b)
Figure 5
Figure 5
Correlation between rotational thromboelastometry FIBTEM maximum clot firmness and chest drain output in first 4 postoperative hours (r = 0.49) (a) and 24 postoperative hours (r = 0.52) (b)

References

    1. Ghasemi A, Horri M, Salahshour Y. Coagulation abnormalities in pediatric patients with congenital heart disease: A literature review. Int J Pediatr. 2014;2:141–3.
    1. Horigome H, Hiramatsu Y, Shigeta O, Nagasawa T, Matsui A. Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia. J Am Coll Cardiol. 2002;39:1072–7.
    1. Despotis GJ, Gravlee G, Filos K, Levy J. Anticoagulation monitoring during cardiac surgery: A review of current and emerging techniques. Anesthesiology. 1999;91:1122–51.
    1. Bolliger D, Szlam F, Levy JH, Molinaro RJ, Tanaka KA. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: Implications for early haemostatic intervention in massive haemorrhage. Br J Anaesth. 2010;104:318–25.
    1. Nuttall GA, Oliver WC, Ereth MH, Santrach PJ. Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1997;11:815–23.
    1. Segal JB, Dzik WH. Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: An evidence-based review. Transfusion. 2005;45:1413–25.
    1. Spalding GJ, Hartrumpf M, Sierig T, Oesberg N, Kirschke CG, Albes JM. Cost reduction of perioperative coagulation management in cardiac surgery: Value of “bedside” thrombelastography (ROTEM) Eur J Cardiothorac Surg. 2007;31:1052–7.
    1. Coakley M, Reddy K, Mackie I, Mallett S. Transfusion triggers in orthotopic liver transplantation: A comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J Cardiothorac Vasc Anesth. 2006;20:548–53.
    1. Lang T, Bauters A, Braun SL, Pötzsch B, von Pape KW, Kolde HJ, et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis. 2005;16:301–10.
    1. Sankarankutty A, Nascimento B, Teodoro da Luz L, Rizoli S. TEG® and ROTEM® in trauma: Similar test but different results? World J Emerg Surg. 2012;7(Suppl 1):S3.
    1. Mauer HM, McCue CM, Caul J, Still WJ. Impairment in platelet aggregation in congenital heart disease. Blood. 1972;40:207–16.
    1. Ismail EA, Youssef OI. Platelet-derived microparticles and platelet function profile in children with congenital heart disease. Clin Appl Thromb Hemost. 2013;19:424–32.
    1. Ogawa S, Szlam F, Chen EP, Nishimura T, Kim H, Roback JD, et al. A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery. Transfusion. 2012;52:14–22.
    1. Saxena P, Bihari C, Rastogi A, Agarwal S, Anand L, Sarin SK. Sonoclot signature analysis in patients with liver disease and its correlation with conventional coagulation studies. Adv Hematol 2013. 2013:237351.
    1. Reinhöfer M, Brauer M, Franke U, Barz D, Marx G, Lösche W. The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis. 2008;19:212–9.
    1. Davidson SJ, McGrowder D, Roughton M, Kelleher AA. Can ROTEM thromboelastometry predict postoperative bleeding after cardiac surgery? J Cardiothorac Vasc Anesth. 2008;22:655–61.
    1. Lee GC, Kicza AM, Liu KY, Nyman CB, Kaufman RM, Body SC. Does rotational thromboelastometry (ROTEM) improve prediction of bleeding after cardiac surgery? Anesth Analg. 2012;115:499–506.
    1. Ti LK, Cheong KF, Chen FG. Prediction of excessive bleeding after coronary artery bypass graft surgery: The influence of timing and heparinase on thromboelastography. J Cardiothorac Vasc Anesth. 2002;16:545–50.

Source: PubMed

3
Subscribe